Remdesivir Can Help Vulnerable Patient Populations: An Interview With Anu Osinusi | Docwire News
great stuff DW
Related Articles
Pneumococcal Vaccine for Children With Sickle Cell Disease | Docwire News
V114, a 15-valent pneumococcal vaccine, was safe and effective in children with sickle cell disease in a phase 3 trial.
How Can Artificial Intelligence Improve Health Care? | Docwire News
Kaushik Gune, US head of Healthcare for Huma Therapeutics Limited, spoke with DocWire about Huma.AI, Huma’s generative AI platform for health care providers.
Fruquintinib Plus Toripalimab Is an Effective Third-Line Treatment of Advanced Colorectal Cancer | Docwire News
Fruquintinib combined with the anti-programmed death-1 antibody toripalimab is effective in treating advanced colon cancer.
Heart Failure | Docwire News
View the latest research on heart failure for cardiologists, including updates to heart failure guidelines, treatment algorithms, clinical trials, and more.
Dr. Nyal Borges Explains Why Microcatheters are Necessary in Interventional Cardiology | Docwire News
Dr. Hady Lichaa speaks with Dr. Nyal Borges about microcatheters, and why there are essential in interventional cardiology.
Case Study: Pulmonary Embolism Mimics Abdominal Pain in a Patient With Sickle Cell Disease | Docwire News
Pulmonary embolism is challenging to diagnose due to its nonspecific symptoms, including abdominal pain.
Oral Therapy Use Has Risen in Patients With MS | Docwire News
Disease-modifying therapies for MS have shifted substantially since 2001, with more patients now taking oral medications.
Can CPAP Improve High-Risk Pregnancies With OSA? | Docwire News
Continuous positive airway pressure therapy improved blood pressure and preeclampsia rates in high-risk pregnancies with OSA.
FDA Grants Full Approval to Game-Changing Drug for Alzheimer Disease | Docwire News
The FDA converted the novel drug Leqembi, the first therapy proven to slow the course of Alzheimer disease, to full approval.